Eylea (Microvascular Complications of Diabetes) Market 2022 - PowerPoint PPT Presentation

About This Presentation
Title:

Eylea (Microvascular Complications of Diabetes) Market 2022

Description:

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. – PowerPoint PPT presentation

Number of Views:170

less

Transcript and Presenter's Notes

Title: Eylea (Microvascular Complications of Diabetes) Market 2022


1
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022byGlobalData
  • Explore all reports for Diabetes Therapeutics
    market
  • _at_
  • http//www.rnrmarketresearch.com/reports/life-scie
    nces/pharmaceuticals/therapeutics/diabetes-therape
    utics .

2
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022
  • The entire market for microvascular complications
    of diabetes (MCD) diabetic nephropathy,
    retinopathy, and neuropathy is facing an
    extremely high level of unmet need across the 7MM
    (US, 5EU and Japan). Despite its enormous
    potential, the MCD market is facing the major
    global barrier in the sparsely populated
    pipeline. The diabetic retinopathy segment of the
    market has recently seen rapid uptake of novel
    anti-VEGF therapies and is experiencing a strong
    growth. On the other hand, the diabetic
    neuropathy and nephropathy segments face the
    barrier in and increasing number of generic
    competitors.
  • Eylea is a fusion protein consisting of
    VEGF-binding portions. It is specifically
    designed to bind to all isoforms of VEGF-A,
    VEGF-B and placental growth factor (PGF), leading
    to their removal from circulation. Decrease in
    VEGF-A levels causes a decrease in macular edema
    by restricting the growth of new blood vessels.
  • Request sample copy of this report _at_
    http//www.rnrmarketresearch.com/contacts/request-
    sample?rname147161 .

3
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022
  • Scope
  • Overview of MCD, including epidemiology,
    etiology, symptoms, diagnosis, pathology and
    treatment guidelines as well as an overview on
    the competitive landscape.
  • Detailed information on Eylea including product
    description, safety and efficacy profiles as well
    as a SWOT analysis.
  • Sales forecast for Eylea for the top seven
    countries from 2012 to 2022.
  • Sales information covered for the US, France,
    Germany, Italy, Spain, the UK and Japan.
  • Complete report available _at_ http//www.rnrmarketre
    search.com/eylea-microvascular-complications-of-di
    abetes-forecast-and-market-analysis-to-2022-market
    -report.html .

4
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022
  • Reasons to buy
  • Understand and capitalize by identifying products
    that are most likely to ensure a robust return
  • Stay ahead of the competition by understanding
    the changing competitive landscape for MCD
  • Effectively plan your MA and partnership
    strategies by identifying drugs with the most
    promising sales potential
  • Make more informed business decisions from
    insightful and in-depth analysis of Eylea
    performance
  • Obtain sales forecast for Eylea from 2012-2022 in
    top seven countries (the US, France, Germany,
    Italy, Spain, the UK and Japan)
  • Request sample copy of this report _at_
    http//www.rnrmarketresearch.com/contacts/request-
    sample?rname147161 .

5
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022
  • Table Of Contents
  • 1 Table of Contents1 Table of Contents 61.1
    List of Tables 91.2 List of Figures 9
  • 2 Introduction 102.1 Catalyst 102.2 Related
    Reports 11
  • 3 Disease Overview 133.1 Etiology and
    Pathophysiology 153.1.1 Diabetic Nephropathy
    153.1.2 Diabetic Retinopathy 173.1.3 Diabetic
    Neuropathy 183.2 Prognosis 19
  • Request sample copy of this report _at_
    http//www.rnrmarketresearch.com/contacts/request-
    sample?rname147161 .

6
Eylea (Microvascular Complications of Diabetes) -
Forecast and Market Analysis to 2022
  • For more details contact Mr. Priyank Tiwari
    sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.
Write a Comment
User Comments (0)
About PowerShow.com